This narrative explores genome editing using CRISPR to transform health outcomes, indicating a potential for future advancements.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
2026 Priestley medalist Jennifer Doudna (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: